ED Patient Views on Pain Care

Author Information (click to view)

Zachary F. Meisel, MD, MPH, MS

Director, Center for Emergency Care Policy Research
Assistant Professor of Emergency Medicine
University of Pennsylvania Perelman School of Medicine
Attending Physician
Hospital of the University of Pennsylvania
Senior Fellow, Leonard Davis Institute of Health Economics
University of Pennsylvania

Zachary F. Meisel, MD, MPH, MS, has indicated to Physician’s Weekly that he has received grants/research aid from the National Institutes of Drug Abuse and the Agency for Healthcare Research and Quality.

Zachary F. Meisel, MD, MPH, MS

Director, Center for Emergency Care Policy Research
Assistant Professor of Emergency Medicine
University of Pennsylvania Perelman School of Medicine
Attending Physician
Hospital of the University of Pennsylvania
Senior Fellow, Leonard Davis Institute of Health Economics
University of Pennsylvania

Zachary F. Meisel, MD, MPH, MS, has indicated to Physician’s Weekly that he has received grants/research aid from the National Institutes of Drug Abuse and the Agency for Healthcare Research and Quality.

Advertisement

Pain continues to be one of the top reasons for patients seeking care at EDs, but little is known about their perspectives and experiences when being treated for pain in this setting. For a qualitative study published in Annals of Emergency Medicine, Zachary F. Meisel, MD, MPH, MS, and colleagues examined important themes surrounding the perspectives and experiences of patients receiving pain treatment in the ED. The authors conducted structured, open-ended telephone interviews with 23 patients who were discharged from the Hospital of the University of Pennsylvania after being seen in the ED during a 4-month period. Most patients were women and between the ages of 18 and 65, and participants were included if they were discharged for pain relating to kidney stones or musculoskeletal injuries.

Key Themes

Study participants discussed a variety of topics relating to their experiences with communication around pain, including views on opioid dependence and addiction as well as patient-provider communication about pain management. “Patients felt that using the typical 1-to-10 pain rating scale was problematic because it limited their interactions with emergency physicians,” says Dr. Meisel. “From the patient perspective, emergency physicians also did not typically discuss alternative pain management options or adequately describe risks of opioid dependence.”

Worries about following prescribed dosing to prevent potential addiction.

Relying on media and other individuals as sources of information about opioids rather than on healthcare providers.

Awareness of the broad tensions that healthcare providers face relating to the prescription of opioid therapy.

In addition, patients with negative experiences relating to their pain management reported having problems communicating with their provider that led to a misunderstanding of their clinical diagnosis. “These patients also described fragmentation of care among their providers and expressed a desire to be involved in the decision-making process around their pain management,” Dr. Meisel says. Patients with positive experiences reported having more regular communication with their care team, having their pain managed rapidly, and having healthcare providers who were empathetic in nature.

Looking Forward

According to Dr. Meisel, there is a clear and significant need for EDs to improve patient education on the risks of opioid misuse. “Patients tend to understand that EDs are busy, but that doesn’t reduce their desire to have meaningful interactions with their providers,” he says. “Patients want to be given information that can help them better understand the causes of their pain and their treatment options. Our findings can be seen as a call to action for ED physicians to discuss pain management more thoroughly with patients. Improving communication is critical to ensuring that patients aren’t denied the option of using opioids if they are good candidates to receive these medications.”